Uterine dehiscence in term pregnant patients with one previous cesarean delivery: Growth factor immunoexpression and collagen content in the scarred lower uterine segment

Article Abstract:

A study to investigate the relationship between the occurrences of uterine dehiscence in term pregnant scarred uteri and the presence of altered biochemical behavior of the scarring process was conducted. The results revealed that uterine dehiscence of scarred uterus may be related to altered biochemical behavior of the scarring process.

Diagnosis, Wound healing, Uterine diseases

---

Impact of menopause on collagen subtypes in the arcus tendineous fasciae pelvis

Article Abstract:

The impact of menopause on the structural components of the arcus tendineous fasciae pelvis (ATFP) is determined. The decrease in the quantity of collagen I in the ATFP, results in a decrease in the ratio of collagen I/(III+V), compromises the tensile strength and increases susceptibility to anterior vaginal wall prolapse.

Biological Product (except Diagnostic) Manufacturing, Drugs, Collagen, Influence, Menopause, Pelvis, Prolapse

---

Similar abstracts:

• Abstracts: Collagen content and growth factor immunoexpression in uterine lower segment of type IA osteogenesis imperfecta: relationship with recurrent uterine rupture in pregnancy
• Abstracts: Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade. part 2
• Abstracts: Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Comparison of amniotic and intramembranous unidirectional permeabilities in late-gestation sheep
• Abstracts: Informed consent, informed refusal, and informed choices. A single nucleotide A>G polymorphism at the position -670 in the Fas gene promoter: Relationship to preterm premature rupture of fetal membranes in multifetal pregnancies
• Abstracts: Inhibin, follicle-stimulating hormone, and age as predictors of ovarian response in in vitro fertilization cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.